In Other News

• New Donor Genetic Marker May Help Predict Stem Cell Transplant Success

• Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

• Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens

• First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

• Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

• Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

• Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

• Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

• Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

• Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

• Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus

• FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

• Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

• Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

• Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

• Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

• Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

• Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

• Electronic Genome Mapping Reveals Structural Abnormalities in Hematologic Malignancies

• Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

• Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

• Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

• Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals